Prodrugs and Drug Delivery
Research group
01.01.2017 -
School of Pharmacy, Faculty of Health Sciences
Leaders
Research in Prodrugs and Drug Delivery group focuses on the chemistry-based methods, especially prodrugs, to overcome drug delivery liabilities of problematic drugs and drug candidates. Our current research is centered on leveraging the body’s natural transport mechanisms for transporting amino acids and glucose, the LAT1 and GLUT1 proteins, respectively, for targeted delivery of drugs and boron carriers for BNCT across the blood-brain barrier (BBB) and cancer cells that express these transporters.
Keywords
Leaders
Doctoral Researchers
Technicians
Other group members
Publications
12 items-
Specific Transport of Temozolomide Does Not Override DNA Repair-mediated Chemoresistance
Bahrami, Katayan; Kärkkäinen, Jussi; Bibi, Sania; Huttunen, Johanna; Tampio, Janne; Montaser, Ahmed B.; Moody, Catherine L; Lehtonen, Marko; Rautio, Jarkko; Wheelhouse, Richard T; Huttunen, Kristiina M. 2024. European journal of pharmaceutical sciences. 195: -
Altering distribution profile of palbociclib by its prodrugs
Järvinen, Juulia; Montaser, Ahmed B; Adla, Santosh Kumar; Leppänen, Jukka; Lehtonen, Marko; Vellonen, Kati-Sisko; Laitinen, Tuomo; Jalkanen, Aaro; Elmquist, William F; Timonen, Juri; Huttunen, Kristiina M; Rautio, Jarkko. 2023. European journal of pharmaceutical sciences. 2024; 192: -
Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT)
Järvinen, Juulia; Pulkkinen, Herkko; Rautio, Jarkko; Timonen, Juri M. 2023. Pharmaceutics. 15: -
Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner
Huttunen, Johanna; Tampio, Janne; Järvinen, Juulia; Montaser, Ahmed B; Markowicz-Piasecka, Magdalena; Huttunen, Kristiina M. 2023. Chemico-biological interactions. 2024; 388: -
Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy
Matović, Jelena; Bahrami, Katayun; Stockmann, Philipp; Sokka, Iris K; Khng, You Cheng; Sarparanta, Mirkka; Hey-Hawkins, Evamarie; Rautio, Jarkko; Ekholm, Filip S. 2023. Molecular pharmaceutics. 20: 3127-3139 -
Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of trans-Cyclooctene-Functionalized Molecular Spherical Nucleic Acids
Auchynnikava, Tatsiana; Aarela, Antti; Liljenback, Heidi; Jarvinen, Juulia; Andriana, Putri; Kovacs, Luciana; Rautio, Jarkko; Rajander, Johan; Virta, Pasi; Roivainen, Anne; Li, Xiang-Guo; Airaksinen, Anu J.. 2023. ACS omega. 8: 45326-45336 -
Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma
Srisongkram, Tarapong; Bahrami, Katayun; Järvinen, Juulia; Timonen, Juri; Rautio, Jarkko; Weerapreeyakul, Natthida. 2022. International journal of molecular sciences. 23: . 8446 -
Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates
Bahrami, Katayun; Järvinen, Juulia; Laitinen, Tuomo; Reinisalo, Mika; Honkakoski, Paavo; Poso, Antti; Huttunen, Kristiina M.; Rautio, Jarkko. 2022. Molecular pharmaceutics. 2023; 20: 206-218 -
Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter
Matović, Jelena; Järvinen, Juulia; Sokka, Iris K; Stockmann, Philipp; Kellert, Martin; Imlimthan, Surachet; Sarparanta, Mirkka; Johansson, Mikael P; Hey-Hawkins, Evamarie; Rautio, Jarkko; Ekholm, Filip S. 2022. ACS omega. 7: 30376-30388 -
Addressing the biochemical foundations of a glucose-based "Trojan horse"-stradegy to boron neutron capture therephy: from chemical synthesis to in vitro assesment
Matovic, Jelena; Järvinen, Juulia; Bland, Helena C; Sokka, Iris K; Imlimthan, Surachet; Ferrando, Ruth Mateu; Huttunen, Kristiina M; Timonen, Juri; Peräniemi, Sirpa; Aitio, Olli; Airaksinen, Anu J; Sarparanta, Mirkka; Johansson, Mikael P; Rautio, Jarkko; Ekholm, Filip S. 2020. Molecular pharmaceutics. 17: 3885-3899